FR2362156A1 - Substances contenant un allergene - Google Patents
Substances contenant un allergeneInfo
- Publication number
- FR2362156A1 FR2362156A1 FR7725051A FR7725051A FR2362156A1 FR 2362156 A1 FR2362156 A1 FR 2362156A1 FR 7725051 A FR7725051 A FR 7725051A FR 7725051 A FR7725051 A FR 7725051A FR 2362156 A1 FR2362156 A1 FR 2362156A1
- Authority
- FR
- France
- Prior art keywords
- substances
- allergen
- substances containing
- immunogenic
- reagins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des substances contenant des allergènes. Ces substances sont des conjugués covalents de molecules d'allergène et de polymères non immunogènes solubles dans l'eau dont le degre de conjugaison est tel qu'ils soient rendus tolérogènes et pratiquement non allergisants et non immunogènes. Les substances de l'invention sont utiles comme médicaments pour la suppression immunospécifique des allergies courantes des mammifères, y compris l'homme, dans lesquelles interviennent les réagines de la catégorie IgE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB34114/76A GB1578348A (en) | 1976-08-17 | 1976-08-17 | Products and a method for the therapeutic suppression of reaginic antibodies responsible for common allergic |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2362156A1 true FR2362156A1 (fr) | 1978-03-17 |
FR2362156B1 FR2362156B1 (fr) | 1981-07-24 |
Family
ID=10361546
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7725051A Granted FR2362156A1 (fr) | 1976-08-17 | 1977-08-16 | Substances contenant un allergene |
Country Status (14)
Country | Link |
---|---|
US (1) | US4261973A (fr) |
JP (1) | JPS5324033A (fr) |
AT (1) | AT359637B (fr) |
AU (1) | AU520366B2 (fr) |
BE (1) | BE857869A (fr) |
CA (1) | CA1091153A (fr) |
CH (1) | CH641681A5 (fr) |
DE (1) | DE2736223A1 (fr) |
DK (1) | DK158359C (fr) |
FR (1) | FR2362156A1 (fr) |
GB (1) | GB1578348A (fr) |
NL (1) | NL7709025A (fr) |
NO (1) | NO148281C (fr) |
SE (1) | SE448147B (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2382458A1 (fr) * | 1976-10-12 | 1978-09-29 | Research Corp | Complexe antigene proteine pour bloquer les reactions allergiques |
WO1995012413A1 (fr) * | 1993-11-03 | 1995-05-11 | O'brien, Caroline, Jane | Regulation et suppression cellulaires |
WO1998059064A1 (fr) * | 1997-06-20 | 1998-12-30 | Boehringer Ingelheim International Gmbh | Complexes pour le transport d'acide nucleique dans des cellules eucaryotes superieures |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0038154B1 (fr) * | 1980-04-15 | 1983-09-21 | Beecham Group Plc | Allergènes modifiés à l'aide de polysarcosines |
EP0077158A1 (fr) * | 1981-10-09 | 1983-04-20 | Beecham Group Plc | Allergènes modifiés |
US4609546A (en) * | 1982-06-24 | 1986-09-02 | Japan Chemical Research Co., Ltd. | Long-acting composition |
US5370871A (en) * | 1983-01-24 | 1994-12-06 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US6022544A (en) | 1983-01-24 | 2000-02-08 | The John Hopkins University | Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry |
US5126131A (en) * | 1983-01-24 | 1992-06-30 | The Johns Hopkins University | Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates. |
US5447722A (en) * | 1983-12-12 | 1995-09-05 | University Of Manitoba | Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals |
US4880635B1 (en) * | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
US5037969A (en) * | 1986-07-03 | 1991-08-06 | Takeda Chemical Industries, Ltd. | Glycosyl derivatives and use thereof |
US4894226A (en) * | 1986-11-14 | 1990-01-16 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
SE458339B (sv) * | 1987-05-25 | 1989-03-20 | Pharmacia Ab | Testremsa foer att paavisa kontaktallergi |
US5116612A (en) * | 1987-06-23 | 1992-05-26 | Allergy Immuno Technologies, Inc. | Immunotherapy agents for treatment of IgE mediated allergies |
US6093699A (en) * | 1987-07-09 | 2000-07-25 | The University Of Manitoba | Method for gene therapy involving suppression of an immune response |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US4990336A (en) * | 1989-02-08 | 1991-02-05 | Biosearch, Inc. | Sustained release dosage form |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5358710A (en) * | 1989-12-01 | 1994-10-25 | Alec Sehon | Method for the suppression of an immune response |
US5126147A (en) * | 1990-02-08 | 1992-06-30 | Biosearch, Inc. | Sustained release dosage form |
US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
AU662155B2 (en) | 1991-05-10 | 1995-08-24 | Celtrix Pharmaceuticals, Inc. | Targeted delivery of bone growth factors |
WO1993012145A1 (fr) * | 1991-12-19 | 1993-06-24 | Baylor College Of Medicine | Conjugues d'alcool polyvinylique ou de polyethyleneglycol de peptides utilises dans l'immunodepression specifique d'epitotes |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
WO1994021281A1 (fr) * | 1993-03-23 | 1994-09-29 | Liposome Technology, Inc. | Composition polymere-polypeptide et procede d'administration de ladite composition |
KR100361933B1 (ko) * | 1993-09-08 | 2003-02-14 | 라 졸라 파마슈티칼 컴파니 | 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트 |
US6030613A (en) * | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US6086875A (en) * | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
DK0876165T3 (da) * | 1995-12-18 | 2007-08-06 | Angiotech Biomaterials Corp | Tværbundne polymersammensætninger og fremgangsmåder til deres fremstilling |
US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
US7883693B2 (en) * | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
WO1998051341A1 (fr) * | 1997-05-14 | 1998-11-19 | The University Of Manitoba | CONJUGUES ANTIGENE-mPEG SUPPRIMANT DES REPONSES IMMUNITAIRES HUMORALES ET A MEDIATION CELLULAIRE |
WO1999022762A1 (fr) | 1997-10-30 | 1999-05-14 | C.B.F. Leti, S.A. | Fragments tolerogenes d'allergenes naturels |
AU764144B2 (en) | 1998-08-28 | 2003-08-14 | Gryphon Therapeutics, Inc. | Polyamide chains of precise length, methods to manufacture them and their conjugates |
US6458953B1 (en) * | 1998-12-09 | 2002-10-01 | La Jolla Pharmaceutical Company | Valency platform molecules comprising carbamate linkages |
GB9913327D0 (en) * | 1999-06-08 | 1999-08-11 | Smithkline Beecham Biolog | Vaccine |
WO2001093914A2 (fr) | 2000-06-08 | 2001-12-13 | La Jolla Pharmaceutical Company | Molecules a plate-forme polyvalentes comprenant un poly(ethylene oxyde) de poids moleculaire eleve |
DE10112825A1 (de) * | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10209822A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid |
DE10209821A1 (de) * | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
BR0308710A (pt) * | 2002-03-26 | 2007-01-09 | Biosynexus Inc | conjugados poliméricos antimicrobianos |
DE10242076A1 (de) * | 2002-09-11 | 2004-03-25 | Fresenius Kabi Deutschland Gmbh | HAS-Allergen-Konjugate |
IL166506A0 (en) * | 2002-09-11 | 2006-01-15 | Fresenius Kabi De Gmbh | Hasylated polypeptides especially hasylated erythropoietin |
US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
ES2314238T3 (es) * | 2002-10-08 | 2009-03-16 | Fresenius Kabi Deutschland Gmbh | Conjugados de oligosacaridos farmaceuticamente activos. |
TWI364295B (en) * | 2002-12-26 | 2012-05-21 | Mountain View Pharmaceuticals | Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
AU2003303635B2 (en) * | 2002-12-26 | 2009-07-23 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates of interferon-beta with enhanced biological potency |
JP2006519766A (ja) * | 2002-12-30 | 2006-08-31 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 組織反応性化合物および組成物、ならびにそれらの使用法 |
JP2006516548A (ja) * | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
WO2005014655A2 (fr) * | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugues d'amidon d'hydroxyalkyle et de proteine |
US20080274948A1 (en) * | 2003-08-08 | 2008-11-06 | Fresenius Kabi Deutschland Gmbh | Conjugates of Hydroxyalkyl Starch and G-Csf |
US20080206182A1 (en) * | 2003-08-08 | 2008-08-28 | Fresenius Kabi Deutschland Gmbh | Conjugates of a Polymer and a Protein Linked by an Oxime Group |
CN101659704A (zh) * | 2004-03-11 | 2010-03-03 | 弗雷泽纽斯卡比德国有限公司 | 通过还原氨基化制备的羟烷基淀粉和蛋白质的偶联物 |
WO2005092369A2 (fr) * | 2004-03-11 | 2005-10-06 | Fresenius Kabi Deutschland Gmbh | Conjugues d'hydroxy-ethyl-amidon et d'erythropoietine |
CN104174071A (zh) | 2004-04-28 | 2014-12-03 | 安希奥设备国际有限责任公司 | 用于形成交联生物材料的组合物和系统及关联的制备方法与用途 |
US20090035784A1 (en) * | 2004-07-30 | 2009-02-05 | Mount Sinai School Of Medicine Of New York University | Npc1l1 and npc1l1 inhibitors and methods of use thereof |
EP1796602A4 (fr) | 2004-09-17 | 2016-10-19 | Angiotech Pharm Inc | Composes multifonctionels pour la formation de biomateriaux reticules et leurs procedes de preparation et d'utilisation |
KR20070110902A (ko) * | 2005-03-11 | 2007-11-20 | 프레제니우스 카비 도이치란트 게엠베하 | 비활성 출발 물질로부터 생물활성 당단백질의 생산 |
TWI299257B (en) * | 2005-05-16 | 2008-08-01 | Tung Hai Biotechnology Corp | γ-POLYGLUTAMIC ACID (γ-PGA, H FORM), γ-POLYGLUTAMATES AND γ-POLYGLUTAMATE HYDROGEL FOR USE AS NUTRITION SUPPLEMENTS IN DIETARY PRODUCTS |
EP1762250A1 (fr) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugués d' amidon hydroxyalkyle et une substance active obtenue par ligation chimique via thiazolidine |
EP2070951A1 (fr) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Procédé de production d'un dérivé hydroxyalkyle de l'amidon avec deux liens |
EP2070950A1 (fr) * | 2007-12-14 | 2009-06-17 | Fresenius Kabi Deutschland GmbH | Dérivés hydroxyalkylés de l'amidon et leur procédé de préparation |
WO2023194333A1 (fr) | 2022-04-04 | 2023-10-12 | Swiftpharma Bv | Protéines de collagène recombinantes renforcées par de la soie d'araignée produites dans des plantes et leur utilisation |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1296529A (fr) * | 1960-03-24 | 1962-06-22 | Leurquin Lab | Procédé de solubilisation de la terpine dans l'eau |
GB1016606A (en) * | 1961-11-08 | 1966-01-12 | Ethan Allan Brown | Therapeutic compositions for injection |
US3487046A (en) * | 1961-04-24 | 1969-12-30 | Georges Negrevergne | Novel pyrazolidone derivatives substituted on the 4 position with a phenolhcho-polyamine ion exchange resin |
FR2346065A1 (fr) * | 1976-03-29 | 1977-10-28 | Muratov Rustem | Dispositif pour le filage des pieces creuses |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1212680B (de) * | 1961-04-17 | 1966-03-17 | Carter Prod Inc | Verfahren zur Herstellung eines injizierbaren, Pollen-Antigene enthaltenden Impfstoffes |
GB1218277A (en) * | 1968-08-20 | 1971-01-06 | Miles Lab | Dry water-dispersible aluminium hydroxide gels |
GB1282163A (en) * | 1969-08-06 | 1972-07-19 | Beecham Group Ltd | Modified allergens and a process for their preparation |
FR2145376A1 (en) * | 1971-07-09 | 1973-02-23 | Mundipharma Ag | Antigens derived from acarids - for asthma treatment and diagnosis |
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
US3869546A (en) * | 1972-12-22 | 1975-03-04 | Cutter Lab | Adjuvant compositions and medicinal mixtures comprising them |
US3920811A (en) * | 1972-12-22 | 1975-11-18 | Cutter Lab | Adjuvant compositions |
-
1976
- 1976-08-17 GB GB34114/76A patent/GB1578348A/en not_active Expired
-
1977
- 1977-08-08 US US05/822,760 patent/US4261973A/en not_active Expired - Lifetime
- 1977-08-09 CA CA284,631A patent/CA1091153A/fr not_active Expired
- 1977-08-11 DE DE19772736223 patent/DE2736223A1/de active Granted
- 1977-08-15 NO NO77772848A patent/NO148281C/no unknown
- 1977-08-16 AT AT592477A patent/AT359637B/de not_active IP Right Cessation
- 1977-08-16 AU AU27942/77A patent/AU520366B2/en not_active Expired
- 1977-08-16 SE SE7709233A patent/SE448147B/xx not_active IP Right Cessation
- 1977-08-16 CH CH1001077A patent/CH641681A5/de not_active IP Right Cessation
- 1977-08-16 DK DK364277A patent/DK158359C/da not_active IP Right Cessation
- 1977-08-16 FR FR7725051A patent/FR2362156A1/fr active Granted
- 1977-08-16 NL NL7709025A patent/NL7709025A/xx not_active Application Discontinuation
- 1977-08-16 JP JP9862977A patent/JPS5324033A/ja active Granted
- 1977-08-17 BE BE180240A patent/BE857869A/fr not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1296529A (fr) * | 1960-03-24 | 1962-06-22 | Leurquin Lab | Procédé de solubilisation de la terpine dans l'eau |
US3487046A (en) * | 1961-04-24 | 1969-12-30 | Georges Negrevergne | Novel pyrazolidone derivatives substituted on the 4 position with a phenolhcho-polyamine ion exchange resin |
GB1016606A (en) * | 1961-11-08 | 1966-01-12 | Ethan Allan Brown | Therapeutic compositions for injection |
FR2346065A1 (fr) * | 1976-03-29 | 1977-10-28 | Muratov Rustem | Dispositif pour le filage des pieces creuses |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2382458A1 (fr) * | 1976-10-12 | 1978-09-29 | Research Corp | Complexe antigene proteine pour bloquer les reactions allergiques |
FR2382460A1 (fr) * | 1976-10-12 | 1978-09-29 | Research Corp | Complexe antigene proteine pour bloquer les reactions allergiques |
WO1995012413A1 (fr) * | 1993-11-03 | 1995-05-11 | O'brien, Caroline, Jane | Regulation et suppression cellulaires |
US6383489B1 (en) | 1993-11-03 | 2002-05-07 | Alec Sehon | Inactivation of granulocytes in the treatment of established allergic responses |
WO1998059064A1 (fr) * | 1997-06-20 | 1998-12-30 | Boehringer Ingelheim International Gmbh | Complexes pour le transport d'acide nucleique dans des cellules eucaryotes superieures |
Also Published As
Publication number | Publication date |
---|---|
AU520366B2 (en) | 1982-01-28 |
JPS5324033A (en) | 1978-03-06 |
GB1578348A (en) | 1980-11-05 |
BE857869A (fr) | 1978-02-17 |
AU2794277A (en) | 1979-02-22 |
NO148281C (no) | 1983-09-14 |
CH641681A5 (de) | 1984-03-15 |
DE2736223C2 (fr) | 1987-04-23 |
DE2736223A1 (de) | 1978-02-23 |
CA1091153A (fr) | 1980-12-09 |
JPH0116812B2 (fr) | 1989-03-27 |
SE7709233L (sv) | 1978-02-18 |
ATA592477A (de) | 1980-04-15 |
NO772848L (no) | 1977-02-20 |
AT359637B (de) | 1980-11-25 |
DK158359C (da) | 1990-10-01 |
US4261973A (en) | 1981-04-14 |
DK364277A (da) | 1978-02-18 |
FR2362156B1 (fr) | 1981-07-24 |
NO148281B (no) | 1983-06-06 |
DK158359B (da) | 1990-05-07 |
NL7709025A (nl) | 1978-02-21 |
SE448147B (sv) | 1987-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2362156A1 (fr) | Substances contenant un allergene | |
HUP9802234A2 (hu) | Eljárás galantamin izolálására, valamint az ezt hatóanyagként tartalmazó gyógyszerkészítmények | |
EA200401473A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
DE69837283D1 (de) | Verwendung von einem phospatidylserine/polypeptide konjugat um autoimmunität hervorzurufen in der behandlung von krebs | |
NL970039I1 (nl) | Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie. | |
WO2003022210A3 (fr) | Compositions pharmaceutiques de conjugues medicament-oligomere et methodes therapeutiques associees | |
NO933028D0 (no) | Peg-interferonkonjugater | |
TR200202231T2 (tr) | Amiloidojenik hastalığın önlenmesi ve tedavisi | |
ATE106013T1 (de) | Arzneimittelfreisetzungssystem aus glucan und adjuvant. | |
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
NO981436D0 (no) | Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav | |
ATE324119T1 (de) | Verwendung von saccharid-konjugaten | |
BE1003009A5 (fr) | Nouvelles compositions pharmaceutiques a base de cyclosporines. | |
DE69231663D1 (de) | Konjugate bestehend aus polysaccharid und protein | |
TR200102493T2 (tr) | IgE'nin C-epsilon-3 veya C-epsilon-4 alanlarından türetilmiş epitoplar veya mimotoplar. | |
FR2446283A1 (fr) | Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques | |
TR199800717T2 (xx) | Amyotrofik lateral skleroz tedavisine y�nelik ila� haz�rlamak i�in | |
DE69422712D1 (de) | Tris-platin-komplexe | |
EP0034214A3 (en) | Use of rosmarinic acid in the treatment of inflammations and pharmaceutical products used therein | |
FR2717081B1 (fr) | Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro. | |
ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
FR2550944B1 (fr) | Association pharmaceutique a base d'anticorps anticellules tumorales et de conjugues cytotoxiques, appropriee notamment pour le traitement des cancers | |
ATE7024T1 (de) | Antiallergische imidodisulfamide. | |
FR2442852A1 (fr) | Nouvelles penicillines et leur application en therapeutique | |
IL125474A0 (en) | Solid instant-release forms of administration and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |